uracil has been researched along with Acquired Immunodeficiency Syndrome in 5 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Excerpt | Relevance | Reference |
|---|---|---|
| "AIDS Clinical Trials Group study A5334s evaluated the pharmacokinetics of raltegravir before and during combined administration of ombitasvir, paritaprevir/ritonavir, plus dasabuvir (OBV/PTV/r + DSV) and weight-based ribavirin in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfected adults." | 9.34 | Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s. ( Alston-Smith, BL; Cohen, DE; Cramer, YS; Morse, GD; Rosenkranz, SL; Schmidt, J; Sulkowski, M; Venuto, CS; Wyles, DL, 2020) |
| "AIDS Clinical Trials Group study A5334s evaluated the pharmacokinetics of raltegravir before and during combined administration of ombitasvir, paritaprevir/ritonavir, plus dasabuvir (OBV/PTV/r + DSV) and weight-based ribavirin in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfected adults." | 5.34 | Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s. ( Alston-Smith, BL; Cohen, DE; Cramer, YS; Morse, GD; Rosenkranz, SL; Schmidt, J; Sulkowski, M; Venuto, CS; Wyles, DL, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venuto, CS | 2 |
| Cramer, YS | 1 |
| Rosenkranz, SL | 1 |
| Sulkowski, M | 1 |
| Wyles, DL | 2 |
| Cohen, DE | 2 |
| Schmidt, J | 1 |
| Alston-Smith, BL | 1 |
| Morse, GD | 2 |
| Balagopal, A | 1 |
| Smeaton, LM | 1 |
| Quinn, J | 1 |
| Vu, V | 1 |
| Alston-Smith, B | 1 |
| Santana-Bagur, JL | 1 |
| Anthony, DD | 1 |
| Sulkowski, MS | 1 |
| Talal, AH | 1 |
| Baba, M | 1 |
| Shigeta, S | 1 |
| Tanaka, H | 1 |
| Miyasaka, T | 1 |
| Ubasawa, M | 1 |
| Umezu, K | 1 |
| Walker, RT | 1 |
| Pauwels, R | 1 |
| De Clercq, E | 1 |
| Araujo, FG | 1 |
| Huskinson, J | 1 |
| Remington, JS | 1 |
| Falcone, A | 1 |
| Darnowski, JW | 1 |
| Ruprecht, RM | 1 |
| Chu, SH | 1 |
| Brunetti, I | 1 |
| Calabresi, P | 1 |
1 review available for uracil and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4-Positive T-Lymphocytes; Drug Combinations; | 1992 |
2 trials available for uracil and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s.
Topics: 2-Naphthylamine; Acquired Immunodeficiency Syndrome; Adult; Anilides; Antiviral Agents; Coinfection; | 2020 |
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy.
Topics: 2-Naphthylamine; Acquired Immunodeficiency Syndrome; Adult; Anilides; Antiviral Agents; Carbamates; | 2020 |
2 other studies available for uracil and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Infective Agents; Atovaquone; Brain; Cell Division | 1991 |
Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Dose-Response Relationship, Drug; Female; Kinet | 1990 |